A new study breathes life into an all-but-dead approach to treating severe Covid-19
Maybe Roche’s IL-6 drug works for Covid-19 after all.
Actemra, the rheumatoid arthritis drug, was widely used by doctors early in the pandemic on the theory that it could douse the overactive immune response that leads to severe symptoms in many patients. But multiple studies in the spring and summer appeared to find that neither the Roche drug nor a similar antibody from Regeneron and Sanofi had any effect.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
